Detalhe da pesquisa
1.
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function.
Breast Cancer Res Treat
; 185(3): 863-868, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400034
2.
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study.
Lancet Oncol
; 21(9): 1155-1164, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32771088
3.
Genomic profiling of breast cancer in African-American women using MammaPrint.
Breast Cancer Res Treat
; 159(3): 481-8, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27568021
4.
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines.
Breast Cancer Res Treat
; 155(2): 285-93, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26749359
5.
Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket study.
Lung Cancer
; 180: 107216, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146473
6.
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer.
Breast Cancer Res Treat
; 125(1): 137-43, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20976541
7.
Video intervention increases participation of black breast cancer patients in therapeutic trials.
NPJ Breast Cancer
; 3: 36, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28944289
8.
Meta-analysis: should it be more than the sum of its parts?
J Natl Cancer Inst
; 102(24): 1817-9, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21098760